SinoMab BioScience Limited — Declaration of Voting Results & Voting Rights Announcements 2021

Feb 19, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [29 x 43] intentionally omitted <==

==> picture [29 x 43] intentionally omitted <==

SinoMab BioScience Limited 中國抗體製藥有限公司

(Incorporated in Hong Kong with limited liability)

(Stock code: 3681)

POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 19 FEBRUARY 2021

The Board is pleased to announce that at the EGM held on 19 February 2021, the ordinary resolution set out in the EGM Notice was duly passed by the Independent Shareholders by way of poll.

Reference is made to the notice of the extraordinary general meeting of SinoMab BioScience Limited（中國抗體製藥有限公司）(the “ Company ”) dated 27 January 2021 (the “ EGM Notice ”) and the Company’s circular dated 27 January 2021 (the “ Circular ”). Unless otherwise stated, capitalized terms used herein shall have the same meanings as those defined in the Circular.

The Board is pleased to announce that the ordinary resolution set out in the EGM Notice was duly passed by the Independent Shareholders by way of poll at the EGM. The Company’s share registrar in Hong Kong, Computershare Hong Kong Investor Services Limited, was appointed as the scrutineer for the poll taking at the EGM. The poll results in respect of the ordinary resolution are as follows:

are as follows:
Ordinary resolution(Note)	Number of Shares voted
	For (%)	Against (%)
To approve and/or ratify the entering into of the Subscription Agreement (including the grant of the Specific Mandate) and the transactions contemplated thereunder.	506,334,565 (100%)	0 (0%)

Note: The full text of the ordinary resolution is set out in the EGM Notice.

1

As at the date of the EGM, the total number of Shares in issue is 1,006,240,400. As stated in the Circular, Haiyao and its associates, in aggregate holding 158,882,115 Shares as at the date of the EGM were required to, and did, abstain from voting on the above ordinary resolution at the EGM. Excluding the Shares held by Haiyao and its associates, the total number of Shares entitling the Independent Shareholders to attend and vote for or against the above ordinary resolution at the EGM was 847,358,285 Shares. No Shareholders were entitled to attend but were required to abstain from voting in favour of the above ordinary resolution at the EGM.

By Order of the Board SinoMab BioScience Limited Dr. Shui On LEUNG Executive Director, Chairman and Chief Executive Officer

Hong Kong, 19 February 2021

As at the date of this announcement, the executive Director is Dr. Shui On LEUNG, the nonexecutive Directors are Dr. Haigang CHEN, Mr. Xun DONG, Mr. Senlin LIU, Ms. Wenyi LIU, Mr. Huiyuan MA and Mr. Jing QIANG, and the independent non-executive Directors are Mr. George William Hunter CAUTHERLEY, Mr. Michael James Connolly HOGAN, Mr. Ping Cho Terence HON and Mr. Dylan Carlo TINKER.

2